Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
IEEE Transactions on Pattern Analysis and Machine Intelligence
|
January 25, 2022
End-to-End Handwritten Paragraph Text Recognition Using a Vertical Attention Network
Denis Coquenet, Clement Chatelain, Thierry Paquet
IEEE Transactions on Pattern Analysis and Machine Intelligence
|
April 5, 2023
DAN: A Segmentation-Free Document Attention Network for Handwritten Document Recognition
Denis Coquenet, Clement Chatelain, Thierry Paquet
IEEE Transactions on Pattern Analysis and Machine Intelligence
|
September 10, 2015
Combining Structure and Parameter Adaptation of HMMs for Printed Text Recognition
Kamel Ait-Mohand, Thierry Paquet, Nicolas Ragot
Clinical Therapeutics
|
March 5, 2013
Effects of hepatic impairment on the pharmacokinetics of everolimus: a single-dose, open-label, parallel-group study
Jan Peveling-Oberhag, Stefan Zeuzem, Wei Peng Yong, et al.
Journal of Hepatology
|
August 10, 2013
Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma
Richard S Finn, Ronnie T P Poon, Thomas Yau, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
IEEE Transactions on Pattern Analysis and Machine Intelligence
|
January 25, 2022
End-to-End Handwritten Paragraph Text Recognition Using a Vertical Attention Network
Denis Coquenet, Clement Chatelain, Thierry Paquet
IEEE Transactions on Pattern Analysis and Machine Intelligence
|
April 5, 2023
DAN: A Segmentation-Free Document Attention Network for Handwritten Document Recognition
Denis Coquenet, Clement Chatelain, Thierry Paquet
IEEE Transactions on Pattern Analysis and Machine Intelligence
|
September 10, 2015
Combining Structure and Parameter Adaptation of HMMs for Printed Text Recognition
Kamel Ait-Mohand, Thierry Paquet, Nicolas Ragot
Clinical Therapeutics
|
March 5, 2013
Effects of hepatic impairment on the pharmacokinetics of everolimus: a single-dose, open-label, parallel-group study
Jan Peveling-Oberhag, Stefan Zeuzem, Wei Peng Yong, et al.
Journal of Hepatology
|
August 10, 2013
Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma
Richard S Finn, Ronnie T P Poon, Thomas Yau, et al.
Page
of 1